Lamb Weston stock rating reiterated at Hold by Stifel with $61 target

Investing.comMonday, September 29, 2025 at 11:59:14 AM
Lamb Weston stock rating reiterated at Hold by Stifel with $61 target
Lamb Weston has received a stock rating of 'Hold' from Stifel, with a target price set at $61. This rating indicates that while the stock is not expected to decline significantly, it may not see substantial growth in the near term either. Investors should consider this cautious outlook as they evaluate their options in the food industry.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Carnival stock holds Buy rating at Stifel on strong 2026 booking trends
PositiveFinancial Markets
Carnival's stock has received a Buy rating from Stifel, reflecting strong booking trends for 2026. This positive outlook is significant as it indicates confidence in the company's recovery and growth potential in the cruise industry, which has faced challenges in recent years. Investors may find this news encouraging as it suggests a rebound in consumer interest and travel plans.
Stifel maintains Hold rating on Waters stock amid BD acquisition plans
NeutralFinancial Markets
Stifel has decided to maintain its Hold rating on Waters Corporation's stock, even as the company plans to pursue acquisitions related to BD. This decision reflects a cautious approach to the potential impacts of these acquisitions on Waters' financial performance. Investors will be watching closely to see how these strategic moves unfold and what they mean for the company's future.
Cytokinetics stock maintains Buy rating at Stifel on promising aficamten data
PositiveFinancial Markets
Cytokinetics has received a Buy rating from Stifel, thanks to promising data on its drug aficamten. This positive assessment highlights the potential of aficamten in treating heart conditions, which could significantly impact patient care and the company's market position. Investors are optimistic about the future as this development may lead to increased stock value and greater interest in Cytokinetics' innovative therapies.
Birkenstock stock rating reiterated at Buy by Stifel on strong growth
PositiveFinancial Markets
Birkenstock's stock has received a Buy rating from Stifel, highlighting the company's strong growth potential. This endorsement is significant as it reflects confidence in Birkenstock's market position and future performance, which could attract more investors and boost the brand's visibility in the competitive footwear industry.
Stifel reaffirms Buy rating on Outset Medical stock at $17 price target
PositiveFinancial Markets
Stifel has reaffirmed its Buy rating on Outset Medical's stock, setting a price target of $17. This is significant as it reflects confidence in Outset Medical's growth potential and market position, which could attract more investors and positively impact the company's stock performance.
Latest from Financial Markets
Startup Founder Charlie Javice Sentenced to More Than 7 Years for Defrauding JPMorgan
NegativeFinancial Markets
Charlie Javice, the founder of the startup Frank, has been sentenced to over seven years in prison for defrauding JPMorgan. Despite acknowledging her mistakes, her legal team is preparing to appeal the conviction. This case highlights the serious consequences of financial fraud in the startup world and raises questions about accountability in the tech industry.
Mexico meat sector decries new livestock movement rules, ivermectin requirement to battle screwworm
NegativeFinancial Markets
The meat sector in Mexico is expressing strong opposition to new regulations that impose restrictions on livestock movement and require the use of ivermectin to combat screwworm infestations. These changes are seen as burdensome and could significantly impact the industry, raising concerns about the economic implications for farmers and producers. The situation highlights the ongoing challenges faced by the agricultural sector in adapting to new health measures while maintaining productivity.
Terawulf Inc stock hits 52-week high at 11.79 USD
PositiveFinancial Markets
Terawulf Inc has reached a significant milestone as its stock hits a 52-week high of 11.79 USD. This achievement reflects growing investor confidence and the company's strong performance in the market. Such highs can attract more attention from potential investors, indicating a positive trend for the company's future.
S&P 500 edges higher ahead of upcoming jobs data, possible government shutdown
NeutralFinancial Markets
The S&P 500 has shown a slight increase as investors await crucial jobs data and consider the implications of a potential government shutdown. This uptick reflects market anticipation and uncertainty, highlighting the importance of upcoming economic indicators that could influence future trading decisions.
Trump to head supervisory board in US peace plan for Gaza
PositiveFinancial Markets
Former President Donald Trump is set to lead a supervisory board for a new peace plan aimed at resolving the ongoing conflict in Gaza. The proposal emphasizes an immediate ceasefire and the release of all remaining hostages, which could pave the way for a more stable and peaceful region. This initiative is significant as it highlights a renewed effort to address long-standing tensions and could potentially lead to a breakthrough in negotiations.
S&P 500, Nasdaq climb as investors brush off shutdown woes, hawkish talk
PositiveFinancial Markets
The S&P 500 and Nasdaq have seen significant gains as investors remain optimistic, despite concerns over a potential government shutdown and hawkish comments from the Federal Reserve. This resilience in the market highlights investor confidence and suggests that many are looking beyond short-term uncertainties, focusing instead on long-term growth opportunities. Such trends are crucial as they can influence economic stability and investment strategies moving forward.